Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_assertion type Assertion NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_head.
- NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_assertion wasGeneratedBy ECO_0000203 NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_provenance.
- NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_assertion wasDerivedFrom befree-20150227 NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_provenance.
- NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_assertion SIO_000772 24432991 NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_provenance.
- NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_assertion evidence source_evidence_literature NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_provenance.
- NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_assertion description "[The proband's cardiometabolic phenotype progression was further characterized: born small for gestational age and adolescence-onset obesity; insulin resistance (homeostasis assessment model of insulin resistance of 4.7), and dyslipidemia at 25 years; decreased high-molecular weight adiponectin (0.24 μg/mL = 10%), hypertension (180/120 mm Hg), steatosis (fat liver = 40% ± 6%), increased carotid intima-media thickness at 31 years, and type 2 diabetes (glycosylated hemoglobin = 6.6%) at 34 years of age.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006843.RABuw7Q6H8kKtIcR9SrGH-1NFn9e7pehTXPFb1fJMmZfI130_provenance.